ePoster 2019
DOI: 10.1136/ijgc-2019-esgo.896
|View full text |Cite
|
Sign up to set email alerts
|

EP847 CA 125 as a prognostic marker for the stage of patients with ovarian carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
0
0
Order By: Relevance
“…Serum CA-125 has been playing significant part in observing, treating and differentiating the recurrence of ovarian cancer and it is a prognostic marker for the advanced stages of ovarian cancers. 6,7 In majority of the ovarian cancers cases, CA-125 was over expressed and its levels at presentation were well correlated with histology. 8,9 Various studies have reported other malignant conditions such as in mesothelioma, breast cancer, gastric cancer, leiomyoma, non-Hodgkin lymphoma (NHL) and leiomyosarcoma of gastrointestinal origin, correlated with raised CA-125 levels.…”
Section: Introductionmentioning
confidence: 98%
“…Serum CA-125 has been playing significant part in observing, treating and differentiating the recurrence of ovarian cancer and it is a prognostic marker for the advanced stages of ovarian cancers. 6,7 In majority of the ovarian cancers cases, CA-125 was over expressed and its levels at presentation were well correlated with histology. 8,9 Various studies have reported other malignant conditions such as in mesothelioma, breast cancer, gastric cancer, leiomyoma, non-Hodgkin lymphoma (NHL) and leiomyosarcoma of gastrointestinal origin, correlated with raised CA-125 levels.…”
Section: Introductionmentioning
confidence: 98%